Sandoz Group AG (VIE:SDZ)

Market Cap	27.16B
Revenue (ttm)	9.01B
Net Income (ttm)	193.29M
Shares Out	n/a
EPS (ttm)	0.45
PE Ratio	140.52
Forward PE	20.34
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	8
Open	62.60
Previous Close	61.94
Day's Range	62.46 - 62.96
52-Week Range	52.52 - 63.78
Beta	n/a
RSI	64.86
Earnings Date	Feb 25, 2026

About Sandoz Group AG

Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, diabetes, immunology, endocrinology, hematology, and ophthalmology. It also provides a portfolio of active pharmaceutical ingredients and finished dosage forms. The company was founded in 1886 and is headquartered in Basel, Switzerland.

• Industry: Pharmaceutical Preparations
• Founded: 1886
• Employees: 22,049
• Stock Exchange: Vienna Stock Exchange
• Ticker Symbol: SDZ

Financial Performance

Financial numbers in USD